サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562195

欧州のPCR技術：2030年までの市場予測 - 地域分析 - 技術、提供、用途、エンドユーザー別

Europe PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User

出版日
ページ情報
英文 147 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
欧州のPCR技術：2030年までの市場予測 - 地域分析 - 技術、提供、用途、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 147 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のPCR技術市場は、2022年の38億8,013万米ドルから2030年には71億7,373万米ドルに成長すると予測されています。2022年から2030年までのCAGRは8.0％を記録すると推定されます。

新興国におけるPCR技術の採用増加が欧州のPCR技術市場を牽引

ポイントオブケア（POC）検査は、そのリーチとアプリケーションの拡大により、PCR技術市場に大きな機会をもたらします。PCR技術は、その精度と感度で知られ、ポイントオブケアまたはその近くで迅速かつ信頼性の高い結果を提供する能力により、POC検査にますます適応されつつあります。POC検査が診療所、救急部、分散型施設などのヘルスケア環境でより普及するにつれて、POCアプリケーション用に調整されたPCRプラットフォームとアッセイに対する需要が高まると予想されます。

高い特異性と感度で感染症を検出する能力を含むPCRの利点は、特に迅速な診断と治療の決定を必要とする状況でのPOC検査に適しています。さらに、PCRシステムの小型化と自動化は、POC設定への統合をさらに可能にし、現場での検査を容易にし、患者の治療成績を向上させる。ヘルスケアプロバイダーが診断能力と患者管理の強化におけるPOC PCR検査の価値をますます認識するにつれ、POC PCR技術市場は成長と革新の態勢を整えています。

欧州のPCR技術市場概要

欧州のPCR技術市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。先進的な研究のために政府や民間団体から提供される資金、人工DNA合成のための革新的な技術の発売、新しい技術に基づくアプリケーションのための様々な調査研究の増加が、欧州のPCR技術市場の成長を促進しています。加えて、研究開発や新しいバイオテクノロジーのスタートアップに対する優遇措置や免税措置を通じてイノベーションを奨励する各国政府の取り組みが、予測期間中の欧州のPCR技術市場の成長に有利に働くと予想されます。ドイツは、著名なバイオテクノロジー企業やハイテク研究所が存在し、科学技術の新分野で研究開発活動を行うための巨額の資金があるため、欧州および世界における最大のバイオテクノロジーハブの一つです。同国には、欧州のどの国よりも多くのバイオテクノロジー企業が存在します。ドイツで進められている最先端の質の高い研究は、すでに確立されているPCR技術市場に有利な機会を生み出しています。この国の個々の研究者や学術大学は、画期的なイノベーションを生み出すために国際的な研究所や機関と協力しています。資金や助成金の増加、様々な応用分野での合成生物学の利用の増加は、ドイツのPCR技術市場の成長を促進する主な要因です。ドイツ政府は新興企業の設立を国内のバイオテクノロジー産業の発展に不可欠なものと考えています。例えば、BIO Deutschlandはベルリンを拠点とするドイツのバイオテクノロジー産業のセクター協会であり、330を超えるメンバーで構成されています。同様に、ユーロネクストもまた、バイオテクノロジー産業の現在の勢いを認識し、活用している組織です。ユーロネクストは、雇用創出、資金調達、投資、その他様々な方法で新興企業を支援しています。

欧州のPCR技術市場の収益と2030年までの予測（金額）

欧州のPCR技術市場セグメンテーション

欧州のPCR技術市場は、技術、提供、用途、エンドユーザー、国にセグメント化されます。

技術に基づき、欧州のPCR技術市場はリアルタイムPCR、コンベンショナルPCR、逆転写、デジタルPCR、マルチプレックスRTPCR、ホットスタートPCR、その他に分類されます。リアルタイムPCRセグメントは2022年に欧州のPCR技術市場で最大のシェアを占めました。

提供の観点から、欧州のPCR技術市場は試薬&消耗品、機器、ソフトウェア&サービスにセグメント化されます。試薬＆消耗品セグメントは2022年に欧州のPCR技術市場で最大のシェアを占めました。さらに、試薬＆消耗品セグメントは試薬、バイアルサイズ、その他の消耗品に分類されます。さらに、バイアルサイズは0.2ml～2ml、0.1ml～0.3ml、2ml～5ml、その他のバイアルに区分されます。さらに、機器セグメントはベンチトップPCRとポータブルサーモサイクラー/PCRに二分されます。

用途別では、欧州のPCR技術市場は遺伝子発現解析、遺伝子配列決定、ジェノタイピング、核酸合成、標準バリデーション、ポイントオブケア診断アプリケーション、環境アプリケーション、その他に区分されます。遺伝子発現解析セグメントは2022年に欧州のPCR技術市場で最大のシェアを占めました。

エンドユーザーに基づき、欧州のPCR技術市場は病院&診断センター、製薬&バイオテクノロジー企業、学術機関&研究所、その他に区分されます。病院＆診断センターセグメントが2022年の欧州のPCR技術市場で最大のシェアを占めました。

国別では、欧州のPCR技術市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に分類されています。ドイツは2022年に欧州のPCR技術市場を独占しました。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc、Ellume Ltdは、欧州のPCR技術市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のPCR技術市場- 主要産業力学

  • PCR技術市場- 主要産業力学
  • 市場促進要因
    • 遺伝性疾患と感染症の有病率の上昇
    • PCR技術への投資と資金の急増
  • 市場抑制要因
    • PCRシステムの高コストと代替アッセイの利用可能性
  • 市場機会
    • POC検査の需要の増加
  • 今後の動向
    • PCR技術の進歩
  • 促進要因と抑制要因の影響

第5章 PCR技術市場：欧州市場分析

  • PCR技術の市場収益、2020年～2030年

第6章 欧州のPCR技術市場分析：技術別

  • リアルタイムPCR
  • コンベンショナルPCR
  • 逆転写PCR
  • デジタルPCR
  • マルチプレックスRT PCR
  • ホットスタートPCR
  • その他

第7章 欧州のPCR技術市場分析：提供別

  • 市場収益シェア、2022年および2030年
  • 試薬および消耗品
  • 装置
  • ソフトウェアとサービス

第8章 欧州のPCR技術市場分析：用途別

  • 市場収益シェア、2022年および2030年
  • 遺伝子発現解析
  • 遺伝子配列決定
  • ジェノタイピング
  • 核酸合成
  • 標準バリデーション
  • ポイントオブケア診断
  • 環境アプリケーション
  • その他

第9章 欧州のPCR技術市場分析：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院および診断センター
  • 学術機関および研究機関
  • 製薬・バイオテクノロジー企業
  • その他

第10章 欧州のPCR技術市場：国別分析

  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州

第11章 PCR技術市場：業界情勢

  • PCR技術市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Takara Bio Inc
  • Standard Biotools Inc
  • Agilent Technologies Inc
  • Ellume Ltd

第13章 付録

図表

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 31. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 32. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 33. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 34. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 36. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 37. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 38. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 39. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 40. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 41. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 42. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 43. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 44. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 45. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 46. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 47. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 48. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 49. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 50. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 53. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. Europe: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Europe PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 36. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 37. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 38. Growth Strategies in the PCR Technologies Market
目次
Product Code: BMIRE00030425

The Europe PCR technologies market is expected to grow from US$ 3,880.13 million in 2022 to US$ 7,173.73 million by 2030. It is estimated to record a CAGR of 8.0% from 2022 to 2030.

Increasing Adoption of PCR Techniques in Emerging Countries Drives Europe PCR Technologies Market

Point-of-care (POC) testing presents a significant opportunity for the PCR technology market by expanding its reach and applications. PCR technology, known for its accuracy and sensitivity, is increasingly being adapted for POC testing due to its ability to deliver rapid and reliable results at or near the point of care. As POC testing becomes more prevalent in healthcare settings such as clinics, emergency departments, and decentralized facilities, the demand for PCR platforms and assays tailored for POC applications is expected to rise.

PCR's advantages, including the ability to detect infectious diseases with high specificity and sensitivity, make it well-suited for POC testing, particularly in situations requiring rapid diagnosis and treatment decisions. Additionally, the miniaturization and automation of PCR systems further enable their integration into POC settings, facilitating on-site testing and improving patient care outcomes. As healthcare providers increasingly recognize the value of POC PCR testing in enhancing diagnostic capabilities and patient management, the market for POC PCR technologies is poised for growth and innovation.

Europe PCR Technologies Market Overview

The European PCR technologies market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Funds made available by government and private organizations for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research studies for novel technology-based applications drive the growth of the PCR technologies market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemptions for R&D and new biotech start-ups are expected to favour the European PCR technologies market growth over the forecast period. Germany is one of the largest biotechnology hubs in Europe and worldwide owing to the presence of prominent biotech players, high-tech research labs, and massive funding for conducting research and development activities in the new areas of science and technology. The country has more biotechnology companies than any other European country. The cutting-edge and high-quality research ongoing in Germany creates lucrative opportunities for the already established market for PCR technologies. Individual researchers and academic universities in the country collaborate with international laboratories and institutions to create breakthrough innovations. The rising funds and grants and increasing use of synthetic biology in various application areas are the major factors favoring the growth of the German PCR technologies market. The German government considers the formation of startups to be an essential part of the development of the biotechnology industry in the country. For instance, BIO Deutschland is a sector association of the German biotech industry based in Berlin, with over 330 members that promote and support the development of the industry to help it bloom as a robust economic entity. Similarly, Euronext is another organization that recognizes and utilizes the current momentum of the biotech industry. It thus assists startups by creating jobs, raising funds and investments, and supporting the companies in various other ways.

Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Europe PCR Technologies Market Segmentation

The Europe PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Europe PCR technologies market is categorized into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Europe PCR technologies market in 2022.

In terms of offerings, the Europe PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Europe PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Europe PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Europe PCR technologies market in 2022.

Based on end user, the Europe PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Europe PCR technologies market in 2022.

By country, the Europe PCR technologies market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Europe PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Europe Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Europe PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Europe PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Europe PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Europe PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Europe PCR Technologies Market -Country Analysis

  • 10.1 Europe: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 Europe PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 Germany
        • 10.1.2.1.1 Overview
      • 10.1.2.2 Germany PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 Germany PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 Germany PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 Germany PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 Germany PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 Germany PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 Germany PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 Germany PCR Technologies Market Breakdown by End User
      • 10.1.2.3 United Kingdom
        • 10.1.2.3.1 Overview
      • 10.1.2.4 United Kingdom PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 United Kingdom PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 United Kingdom PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 United Kingdom PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 United Kingdom PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 United Kingdom PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 United Kingdom PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 United Kingdom PCR Technologies Market Breakdown by End User
      • 10.1.2.5 France
        • 10.1.2.5.1 Overview
      • 10.1.2.6 France PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.1 France PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.1.1 France PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.1.2 France PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.1.2.1 France PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.2 France PCR Technologies Market Breakdown by Application
        • 10.1.2.6.3 France PCR Technologies Market Breakdown by End User
      • 10.1.2.7 Italy
        • 10.1.2.7.1 Overview
      • 10.1.2.8 Italy PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.1 Italy PCR Technologies Market Breakdown by Technology
        • 10.1.2.8.2 Italy PCR Technologies Market Breakdown by Offerings
        • 10.1.2.8.2.1 Italy PCR Technologies Market Breakdown by Instruments
        • 10.1.2.8.2.2 Italy PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.8.2.2.1 Italy PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.8.3 Italy PCR Technologies Market Breakdown by Application
        • 10.1.2.8.4 Italy PCR Technologies Market Breakdown by End User
      • 10.1.2.9 Spain
        • 10.1.2.9.1 Overview
      • 10.1.2.10 Spain PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.1 Spain PCR Technologies Market Breakdown by Technology
        • 10.1.2.10.2 Spain PCR Technologies Market Breakdown by Offerings
        • 10.1.2.10.2.1 Spain PCR Technologies Market Breakdown by Instruments
        • 10.1.2.10.2.2 Spain PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.10.2.2.1 Spain PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.10.3 Spain PCR Technologies Market Breakdown by Application
        • 10.1.2.10.4 Spain PCR Technologies Market Breakdown by End User
      • 10.1.2.11 Rest of Europe
        • 10.1.2.11.1 Overview
      • 10.1.2.12 Rest of Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.12.1 Rest of Europe PCR Technologies Market Breakdown by Technology
        • 10.1.2.12.2 Rest of Europe PCR Technologies Market Breakdown by Offerings
        • 10.1.2.12.2.1 Rest of Europe PCR Technologies Market Breakdown by Instruments
        • 10.1.2.12.2.2 Rest of Europe PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.12.2.2.1 Rest of Europe PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.12.3 Rest of Europe PCR Technologies Market Breakdown by Application
        • 10.1.2.12.4 Rest of Europe PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Takara Bio Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Standard Biotools Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Agilent Technologies Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Ellume Ltd
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms